AI-Driven Literature Curation for Determining Genomic Variant Pathogenicity

Mark Kiel, Founder and Chief Science Officer of Genomenon was a featured presenter for the LabRoots Virtual Genetics & Genomics Event on May 8th and 9th, 2019. This is the transcript, slides and video from his talk, which opened the event on Thursday, May 9th.

Read more

Genomenon Honored as one of 50 Companies to Watch 2019

Mike Klein, CEO of Genomenon, as interviewed by Jeffrey Mosher, Operations Director of Michigan Business Network on Genomenon’s recent award as one of the Top 50 Companies to Watch in Michigan.

Read more

Don’t Call It a Comeback

Mark Kiel, Founder and Chief Science Officer of Genomenon, shares his comeback story at Startup Story Night 2019 at the Marble Bar in Detroit. Genomenon has come a very long way. Like any good story, we had our ups and downs, moments of excitement and fear while rapidly growing in a developing industry. Read about …

Read more

Top Cited Genomic Variants in 2017 – Highlighting EGFR p.C797S

Original version of this post was previously published on the Enlightenbio Blog on January 1, 2018 by Brigitte Ganter.  Dr. Mark Kiel (CSO and co-Founder at Genomenon) and Lauren Chunn (Data Processing Analyst at Genomenon) were able to mine the Mastermind database of genomic variants and analyze the trending citations of widely covered variants in the …

Read more

First Automated Blood Cancer Gene Panel Published

At an AMP 2017 Corporate Workshop on Wednesday, November 15th, Dr. Mark Kiel announced the details of the first automated, evidence-based pan-hematopoietic malignancy blood cancer gene panel.

Read more

Genomenon Disrupts NGS Industry with Free Genomic Search Engine

Genomenon disrupted the NGS Industry by offering a free edition of the Mastermind Genomic Search Engine at the ASHG conference last month and it has announced it will extend the invitation to AMP 2017.

Read more